Implementing TMB measurement in clinical practice: considerations on assay requirements
Clinical evidence demonstrates that treatment with immune checkpoint inhibitor immunotherapy agents can have considerable benefit across multiple tumours. However, there is a need for the development of predictive biomarkers that identify patients who are most likely to respond to immunotherapy. Com...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/4/1/e000442.full |